Pathfinder TB-TST en el 14o Congreso Europeo de Medicina Tropical y Salud Internacional - Hamburgo 2025
The Global Health Network Latin America and the Caribbean participated in the European Congress on Tropical Medicine and International Health (ECTMIH) 2025
The Global Health Network Latin America took part in the European Congress on Tropical Medicine and International Health (ECTMIH) 2025, presenting the results of the Pathfinder Argentina conducted by the Argentine research team at the Institute for Clinical Effectiveness and Health Policy (IECS). The study explored the challenges of conducting a clinical trial during the COVID-19 pandemic.
The findings from the study, “Tuberculosis Treatment Support Tools Trial (TB-TST): Pathfinder to map operational and ethical barriers to study initiation during the COVID-19 pandemic,” were showcased in a poster presentation.
Representing both the Host and Pathfinder TB-TST teams, Dr Fernando Rubinstein, principal investigator of the clinical trial, and Lic. Daniela Moraes Morelli attended the poster exhibition. Morelli highlighted the strong interest from researchers across Africa, Australia, and Latin America in the analysis of operational and ethical challenges faced by the TB-TST study during the COVID-19 pandemic in Argentina.
Using the Pathfinder approach, the Argentine research team, led by Dr Javier Roberti, identified regulatory, logistical, and ethical barriers, and proposed mitigation and resilience strategies that helped preserve scientific integrity during one of the greatest global public health challenges of recent decades.
The Host study was funded by the National Institutes of Health (NIH) (Grant R01 AI147129-02), and the Pathfinder project by Wellcome (Grant 226688/Z/22/Z).
The Global Health Network América Latina y Caribe participou do Congresso Europeu de Medicina Tropical e Saúde Internacional (ECTMIH) 2025
A Global Health Network América Latina participou do Congresso Europeu de Medicina Tropical e Saúde Internacional (ECTMIH) 2025, apresentando os resultados do Pathfinder Argentina conduzido pela equipe argentina de pesquisa do Instituto de Efectividade Clínica e Sanitária (IECS). O estudo explorou os desafios de realizar um ensaio clínico durante a pandemia de COVID-19.
Os achados do estudo “Tuberculosis Treatment Support Tools Trial (TB-TST): Pathfinder to map operational and ethical barriers to study initiation during the COVID-19 pandemic” foram apresentados em formato de pôster.
Representando as equipes Host e Pathfinder TB-TST, estiveram presentes o Dr. Fernando Rubinstein, investigador principal do ensaio clínico, e a Lic. Daniela Moraes Morelli, que destacou o grande interesse de pesquisadores da África, Austrália e América Latina na análise dos desafios operacionais e éticos enfrentados pelo estudo TB-TST durante a pandemia de COVID-19 na Argentina.
Aplicando a abrodagem Pathfinder, a equipe argentina de pesquisa, liderada pelo Dr. Javier Roberti, identificou barreiras regulatórias, logísticas e éticas, e propôs estratégias de mitigação e resiliência que permitiram manter a integridade científica durante um dos maiores desafios globais em saúde pública das últimas décadas.
O estudo Host foi financiado pelo National Institutes of Health (NIH) (R01 AI147129-02) e o projeto Pathfinder pela Wellcome (226688/Z/22/Z).
Support the community
Thank you for visiting The Global Health Network, please take a moment to read this important message. As you know, our aim is to enable equity in access to research knowledge and this is successfully delivering support and training to 1000’s of research teams all over the world. But we need your support!. If you have benefited from this research skills and knowledge sharing facility, please help us sustain this remarkable and unique provision of information for those who could otherwise not access such support and training. We would be really grateful if you could make a donation or ask your employer or organisation to contribute to the costs of maintaining this platform and the generation of new contents for all users. Just a small contribution from everyone who can afford to pay would keep this available for those who cannot. Thank you, we really appreciate your part in this community effort to better equity in global health research.